INTRODUCTION {#sec1-1}
============

Scope {#sec2-1}
-----

This standard operating procedure (SOP) document has been specially compiled for the implementation of non-commercial culture and drug susceptibility testing (DST) methods endorsed by New Diagnostic Working Group (NDWG)-STOP tuberculosis (TB) Partnership (WHO) for laboratory network performing the rapid non-commercial rapid culture identification and DST for *Mycobacterium tuberculosis* and intended for the use of TB Diagnostic Laboratories, located in various Asian countries. It is also intended as a companion to the TB laboratory training manuals.

This SOP describes the procedure for the nitrate reductase assay (NRA) that detects the ability of *M. tuberculosis* to reduce nitrate to nitrite, which is also used as the biochemical test for mycobacterial species. The presence of nitrite can be easily detected using specific reagents. The incorporation of drugs in the medium allows it to be used as DST. The rapid detection of *M. tuberculosis* and information about DST allows proper management of TB.

As suspensions with viable, infectious bacteria are handled, strict compliance with safety and protection measures are mandatory. The procedure must be carried out in a laboratory meeting the WHO standards for biosafety level 2 with access restricted to authorized personnel only.

Purpose {#sec2-2}
-------

The purpose of this SOP is to rapidly provide clinicians with information about the patients suspected to have multidrug resistant *M. tuberculosis* for proper clinical management.

Personnel qualifications {#sec2-3}
------------------------

The test performer should be having a diploma in laboratory technologies and preferably university graduate in biological sciences with sufficient experience.

### Medical fitness {#sec3-1}

In accordance with the national laws and practices, arrangements should be made for appropriate health surveillance of TB laboratory workers:

Before enrolment in the TB laboratoryAt regular intervals thereafter, annually or bi-annuallyAfter any biohazard incidentIn case of onset of TB symptoms

All cases of disease or death identified in accordance with national laws and/or practice as resulting from occupational exposure to biological agents shall be notified to the competent authority.

### Education and training {#sec3-2}

Personnel are required to be knowledgeable about the procedures in this SOP. Documentation of training and familiarization with this SOP can be found in the training file for each employee.

The laboratory staff shall confirm (i.e., documentation in the training file of familiarization with the SOP) that they can properly perform the procedure before commencing work. Education and training must be given on the following topics:

Potential risks to health (symptoms of TB disease and transmission)Precautions to be taken to minimize aerosol formation and prevent exposureHygiene requirementsWearing and use of protective equipment and clothing;Handling of potentially infectious materialsLaboratory design, including airflow conditionsUse of biological safety cabinets (BSC) (operation, identification of malfunctions, maintenance)Use of autoclaves, incubators (operation, identification of malfunctions, maintenance)Prevention of incidents and steps to be taken by workers in the case of incidents (biohazard incidents, chemical, electrical, and fire hazards)Good laboratory practice and good microbiological techniquesOrganization of workflowProceduresWaste managementImportance of laboratory results for patient managementImportance of laboratory results for the national TB programTraining shall be given before a staff member takes up his/her postRepeat training periodically, preferably every year

Bio-safety precautions in tuberculosis laboratory {#sec2-4}
-------------------------------------------------

TB laboratory has all the major facility requirements for handling *M. tuberculosis* safely, and involves minimum risk to the laboratory personnel if they take proper precautions, and employ proper techniques described in these SOPs. Laboratory safety involves all the procedures and methods one needs to follow to minimize the risks of laboratory acquired infections. Use of laboratory is limited to trained TB lab personnel.

### Biological safety cabinets {#sec3-3}

Switch ON the safety cabinets for at least 30 min before use. Note that the reading on the mini gauge pressure is satisfactoryWear double pair of gloves, every time you work inside the cabinetBiosafety cabinets need to be cleaned with 5% phenolic or 1% hypochlorite solution before workKeep disposal bin/vessel with 5% phenolic or 5% hypochlorite disinfect inside the cabinet at the right side cornerWipes of gauge-cloth soaked in 5% phenolic or 5% hypochlorite, should be readily available inside the cabinetArrange all un-infected material required towards the left sideAll the processed samples need to be arranged right sideDo not process more than six specimens at a time, inside the cabinetAfter completion of work, wipe off the surface with 5% phenolic solution, and discard all wipes in biohazard bags, or in disposal container meant for infectious materialsDiscard off the outer glove, too, inside the bio-safety cabinetWipe off the inner glove with disinfectant before touching anything else in the lab

### Waste disposal and handling {#sec3-4}

All infectious waste should be discarded in the bio-safety disposal bin. All infectious solid waste-wipes, swabs, plastic, paper towels, gauze pads, gloves, etc., should be placed inside the double autoclave bags, sealed with autoclave tape and sterilized at 121°C for 30 min in the autoclave.

Liquid waste, in the steel discarding bins, should be disinfected in 5% phenol for at least 1 h, before sealing the caps and autoclaved at 121°C for 30 min.

Accidents and spillages {#sec2-5}
-----------------------

**Spills inside biological safety cabinet**All workers using the bio-safety cabinets should keep absorbent materials (gauge cloth/adsorbent sheet) and 5% phenol within the cabinet.Alert all people in lab of immediate area of in the event of spillSpread 5% phenol soaked wipe immediately, while the BSC continues to operate. Wait for 15-20 min.Use paper towels to wipe the spill, working from the edges into the centerDecontaminate equipment: Items that are not readily or easily surface decontaminated should be carefully placed into autoclave bags and removed for further treatment (e.g., decontamination by autoclaving)Contaminated gloves and clothes (sleeves are most likely to be contaminated); remove and decontaminate the lab coat by autoclaving or soaking in decontaminant.**Spills outside containment room in the BSC**Spills on equipment (such as vortex, centrifuge, incubator, refrigerator etc.), laboratory benches, walls, or floors:Immediately indicate to all the personnel working in the lab, and evacuate for 1 h to allow dissipation of aerosols created by the spill (negative air pressure system would clear the aerosols)Leave the BSC operating and cultures inside the cabinetLeave the containment facility following exit proceduresClose laboratory doors and post warning signs to prevent others from entering the laboratoryThoroughly wash hands and other apparently contaminated areas with soap and water. Put on clean disposable glovesIf personal clothing is contaminated, remove all outer clothing and place it in the autoclave or container for autoclaving. Put on clean garmentsUpon returning to the laboratory wear the N95 mask, fresh lab coat and double pair gloves to start decontamination, cover the spill area with paper towels soaked in 5% phenol solution or 1:10 dilution of 20% bleach (freshly prepared), or 70% ethanol solution (do not pour decontamination solution directly onto the spill in order to avoid additional release of aerosols)Let it stand for 20 min then wipe up with paper towelsWipe up the spill with the soaked paper towels and place the used towels in an autoclave bag and autoclavePlace gloves and paper towels in autoclave bag and autoclaveSpill inside the centrifuge bucket/tube: Always use the aerosol containment cups for centrifuging. Always open the centrifuge buckets inside the bio-safety cabinet. Autoclave the bucketsWash hands and other apparently contaminated areas again with soap and water**Dont\'s**Eating, drinking, smoking, applying cosmetics, use of mobile phones, or applying contact lenses in the TB laboratoryDo not allow unauthorized personnel to enter the TB laboratoryMouth pipettingCrowding of lab with material that is not required inside

PROCEDURE {#sec1-2}
=========

Principle {#sec2-6}
---------

NRA on solid medium is based on the ability of *M. tuberculosis* to reduce nitrate to nitrite, the presence of which can be easily detected with specific reagents that produce a color change. It can be applied on solid medium either indirectly using strains or directly using samples resulting in a dramatic reduction of time needed to obtain the results. NRA uses the detection of nitrite as an indication of growth when it is used as a DST.

Inability of *M. tuberculosis* to grow in the presence of *p*-nitrobenzoate (PNB) is one of the key elements to differentiate tubercle bacilli from other mycobacterial species and is part of the identification process for *M. tuberculosis*. *M. tuberculosis* and other tubercle bacilli will not grow on culture medium containing PNB.

Samples {#sec2-7}
-------

Clinical sample for direct NRAPure cultures of *M. tuberculosis* grown on solid/liquid medium for indirect NRA

Equipment and materials {#sec2-8}
-----------------------

BSC, class II, annually certifiedIncubator set at 37°CAutoclaveBalanceRefrigerator/freezerVortexAutomatic micropipettes (1000 μl, 200 μl, and 20 μl)

Reagents and solutions preparation {#sec2-9}
----------------------------------

PNB solution (Sigma-Aldrich, ref. 227056): Prepare stock of (200 mg/ml). Weigh 2 g PNB (Sigma, ref. 72910) and dissolve in 10 ml dimethylformamide. Final concentration to be used is 500 μg/mlPotassium nitrate (Sigma, ref. P-8394): Prepare stock of 200 mg/ml. Weigh 2 g potassium nitrate and dissolve in 10 ml sterile DW. Final concentration to be used is 1000 μg/ml. (Note: Sodium nitrate can be used in place of potassium nitrate, depending on availability)Hydrochloric acid (HCl) (Merck, ref. HB9H590082): Prepare 50% (v/v) concentrated HCl. Add 10 ml concentrated HCl to 10 ml sterile distilled water (DW)Sulphanilamide (Merck, ref. 1.11799.0100): Prepare 0.2% (w/v) sulphanilamide. Weigh 0.1 g of sulphanilamide and dissolve in 50 ml sterile DW*n*-1-Naphthylethylenediamine dihydrochloride (Merck, ref. 1.06237.0005): Prepare 0.1% (w/v) *n*-1-naphthylethylenediamine dihydrochloride. Weigh 0.05 g of *n*-1-naphthylethylenediamine dihydrochloride and dissolve in 50 ml sterile DWMineral salt solution for Löwenstein-Jensen (L-J): For 600 ml, potassium dihydrogen phosphate anhydrous (KH ~2~ PO ~4~ ) (Merck, ref. 1048729025) - 2.4 g, magnesium sulphate (MgSO ~4~·7H ~2~ O) (Qualikems, ref. M009112) - 0.24 g, magnesium citrate - 0.6 g, asparagine (SRL, ref. 014035) - 3.6 g, glycerol (Merck, ref. 356350) - 12 ml, and DW - 600 mlDissolve the ingredients in order in DW by heating. Autoclave at 121°C, 30 min to sterilize. Cool to room temperature. This solution can be kept indefinitely and may be stored in suitable amounts in the refrigeratorMalachite green (oxalate) (Merck, ref. MB6M560027): Prepare 2% malachite green solution. Weigh 2.0 g of malachite green dye and using aseptic techniques dissolve the dye in 100 ml sterile DW by placing the solution in the incubator for 1-2 h. Filter before use

Drug solutions and dilutions {#sec2-10}
----------------------------

Drugs: Rifampicin (RIF) (Sigma, ref. R7382) and isoniazid (INH) (Sigma, ref. I3377).

For drug stock preparation refer to [Table 1](#T1){ref-type="table"}. For preparation of drug dilutions to be used in medium refer to [Table 2](#T2){ref-type="table"}.

###### 

Preparation of drug stock

![](JLP-4-112-g001)

###### 

Preparation of drug dilutions to be used in medium
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Löwenstein-Jensen (L-J) Medium {#sec2-11}
------------------------------

Fresh eggsMineral salt solutionMalachite green solution, 2%Stock of potassium nitrateStock of PNBDrug solutions: INH and RIFOther material: 2 l Erlenmeyer with stopper; glass funnel; 1 l measuring cylinder; 25 ml measuring cylinder; sterile cotton gauze; sterile blunt end forceps; blender; inspissator

### Preparation of the media {#sec3-5}

**Homogenized whole eggs**Fresh hens\' eggs, not more than 7 days old, are cleaned by scrubbing thoroughly with a hand brush in warm water and plain alkaline soap. Let the eggs soak for 30 min in the soap solution. Rinse eggs thoroughly in running water and soak them in 70% ethanol for 15 min. Before handling the clean dry eggs scrub the hands and wash them. Crack the eggs with a sterile forceps into a sterile flask and beat them with a sterile egg whisk or with a sterile blender.**Complete medium**The following ingredients are aseptically pooled in a large, sterile flask, and mixed well:Mineral salt solution, 600 mlMalachite green solution, 20 mlHomogenized eggs (20-25 eggs, depending on size), 1000 mlDivide medium in three different portions: Nitrate control, PNB control, and drug-containing medium.Nitrate control: Potassium nitrate stock 0.2 g/ml - add 5 ml of stock to 1000 ml of medium.PNB control: PNB stock 0.2 g/ml - add 2.5 ml of stock to 1,000 ml of medium.**Drug-containing medium**Divide this portion again in two parts and add drugs to medium as per given in [Table 2](#T2){ref-type="table"} as well as add potassium nitrate.The complete egg medium is distributed in 6-8 ml volumes in sterile 28 ml McCartney bottles or in 20 ml volumes in 20 × 150 mm screw-capped test tubes and the tops are securely fastened. Inspissate the medium within 15 min of distribution to prevent sedimentation of the heavier ingredients.**Coagulation of medium**Before loading, heat the inspissator to 80°C to quicken the build-up of the temperature. Place the bottles in a slanted position in the inspissator and coagulate the medium for 45 min at 80-85°C (since the medium has been prepared with sterile precautions this heating is to solidify the medium, not to sterilize it). Heating for a second or third time has a detrimental effect on the quality of the medium. The quality of egg media deteriorates when coagulation is done at too high a temperature or for too long. Discoloration of the coagulated medium may be due to excessive temperature. The appearance of little holes or bubbles on the surface of the medium also indicates faulty coagulation procedures. Poor quality media should be discarded.

### Sterility check {#sec3-6}

After inspissation, the whole media batch or a representative sample of culture bottles should be incubated at 35 - 37°C for 24 h as a check of sterility.

### Storage {#sec3-7}

The L-J medium should be dated and stored in the refrigerator and can be kept for several weeks if the caps are tightly closed to prevent drying out of the medium. For optimal isolation from specimens, L-J medium should not be older than 4 weeks.

Procedure for direct nitrate reductase assay : Using clinical sample {#sec2-12}
--------------------------------------------------------------------

### Samples not requiring decontamination {#sec3-8}

The following specimens usually do not need decontamination when aseptically collected into sterile containers:

Spinal or other internal body fluids but should be collected asepticallyBone marrow aspirate if collected asepticallyPus from closed cold abscesses such as fine needle aspiration cytology (FNAC) materialSurgically resected specimens (excluding autopsy material)Material obtained from pleural, liver, and lymph nodes as well as biopsies (if not fistulised).

For samples requiring decontamination process the specimen Process the specimen with sodium hydroxide-N-acetyl-l-cysteine (NaOH-NALC) modified Petroff\'s method.

### Reagents required {#sec3-9}

4% NaOH2.9% sodium citrate dehydrate or 2.6% sodium citrate anhydrousNALCAnhydrous disodium hydrogen phosphate (Na ~2~ HPO ~4~ )Mono-potassium dihydrogen phosphate (KH ~2~ PO ~4~ )DW

### Procedure for decontamination of sputum using sodium hydroxide-N-acetyl-l-cystein: Modified Petroff\'s method {#sec3-10}

**Preparation of NaOH-NALC**The mucolytic agent, NALC is used for rapid digestion of sputum and this enables the decontaminating agents like NaOH, to be used at a lower concentration (in sputum) of 1%The NaOH and sodium citrate may be mixed as given in [Table 3](#T3){ref-type="table"}, sterilized and stored in sterile screw cap bottle for use. After NALC has been added, the prepared volume of digestant must be used within 24 h as NALC loses mucolytic activity on standing for long. (Note: Acetyl-cysteine loses activity rapidly in solution, so should be made fresh daily. Sodium citrate is included in the digestant mixture to bind the heavy metal ions that might be present in the specimen and could inactivate the specimen and could inactivate the acetyl-cysteine.)For preparation of NaOH-NALC solution refer to [Table 3](#T3){ref-type="table"}.**Preparation of 0.067 M phosphate buffer (pH 6.8)**For stock solutions:Disodium phosphate: Dissolve 9.47 g of anhydrous Na ~2~ HPO ~4~ in 1 l of DWMono-potassium phosphate: Dissolve 9.07 g of KH ~2~ PO ~4~ in 1 l of DWTo prepare pH 6.8 buffer solution, mix 50 ml of (a) with 50 ml of (b) prepared aboveCheck pHIf final buffer requires pH adjustments, add solution (a) to raise the pH or solution (b) to lower it

###### 

Preparation of sodium hydroxide-N-acetyl-l-cysteine solution

![](JLP-4-112-g003)

### Sample processing {#sec3-11}

Transfer a maximum volume of 3-5 ml of specimen to a sterile 50 ml centrifuge tube (aerosol free and graduated)Add equal volume of NALC-NaOH-Na citrate solution asepticallyMix the control for approximately 20 s on vortex mixture. Be sure to invert the tube so that NALC-NaOH comes in contact with the entire surface of the tubeAllow the mixture to stand at room temperature for 15 min to decontaminate the specimen with occasional gentle shaking of handDilute the mixture by adding sterile phosphate buffer (pH 6.8) upto the 50 ml mark on the tube and recap itCentrifuge the tube at 3000g for 15 minDecant the supernatant

### Preparation of inoculum {#sec3-12}

Re-suspend the pellet with 2 ml phosphate buffer (pH 6.8)Prepare 1:10 dilution of re-suspended pellet in 0.067 M phosphate buffer for inoculation of control tubes (add 0.2 ml of the re-suspended pellet in 0.8 ml phosphate buffer)

### Inoculation of nitrate reductase assay tubes {#sec3-13}

0.2 ml of the 1:10 dilution is inoculated in three drugs free tubes (control tube containing potassium nitrate)0.2 ml of the undiluted suspension is inoculated into the drug-containing tube0.2 ml of the undiluted suspension is inoculated into the PNB containing tubeIncubate at 37°C until 14 day

Reading of tubes {#sec2-13}
----------------

Reagent mixture: One part of 50% (v/v) concentrated HCl, two parts of 0.2% (w/v) sulfanilamide and two parts of 0.1% (w/v) *n*-1-naphthylethylenediamine dihydrochloride. These are mixed shortly before use.

After 14 days of incubation, 0.5 ml of a reagent mixture will be added to one drug free tube. If any color occurs, the corresponding antibiotic containing tube will be developed by the reagent mixture. If no color change occurs, the tube will be discarded and the other tubes will be re-incubated. The procedure will be repeated at day 21 using the second growth control tube, and if is necessary, also at day 28 using the third growth control tube. Also observe tube with PNB.

Procedure for indirect nitrate reductase assay - Using pure cultures of acid-fast bacilli grown on solid/liquid medium {#sec2-14}
----------------------------------------------------------------------------------------------------------------------

### Preparation of 7H9-S {#sec3-14}

Middle brook 7H9 broth supplemented with 10% oleic acid dextrose catalase and 0.2% glycerol.

### Preparation of inoculum {#sec3-15}

Confirm the growth as*M. tuberculosis* (MTB) using either PNB or MPT-64 rapid test or other methods being practiced in the local laboratory.

**Inoculum from growth on solid medium**It is very important to have fresh growth on a solid medium (21-28 days old). Older cultures may result in unreliable susceptibility test results.Take a loop full of bacterial growth with a sterile loop and put it in a sterile vial with glass beads just covering the bottom of the vial with 2.5 ml of 7H9-S broth (try not to take any medium when removing growth)Vortex the vial for at least 1 min to break the clumps until a fairly turbid suspension is obtained.Allow it to stand for 5 minTransfer the supernatant to a new sterile vial and leave it to sediment for 15 minTransfer the supernatant to a new sterile vialCompare the turbidity of the suspension using the scale McFarland 1.0 standardSet the turbidity of inoculum as per McFarland 1.0 standard using 0.067 M phosphate buffer (pH 6.8)**Inoculum from a liquid medium**It is very important to have fresh growth in liquid medium (21-28 days old). Older cultures may result in unreliable susceptibility test results.Transfer 2.5 ml of the culture pellet to a sterile vial containing glass beadsVortex for at least 1 min until a fairly turbid suspension is obtainedAllow it to stand for 5 minTransfer the supernatant to a new sterile vial and leave it to sediment for 15 minTransfer the s upernatant to a new sterile vialCompare the turbidity of the suspension using the scale McFarland 1.0 standardSet the turbidity of inoculum as per McFarland 1.0 standard using 0.067 M phosphate buffer (pH 6.8)

### Dilution of the inoculum {#sec3-16}

The inoculum turbidity (from liquid or solid culture) is adjusted to a McFarland tube no. 1 and further diluted to 1:10 in 0.067 M phosphate buffer (pH 6.8).

### Inoculation of nitrate reductase assay tubes {#sec3-17}

0.2 ml of the 1:10 dilution is inoculated in three drugs free tubes (control tubes containing potassium nitrate)0.2 ml of the undiluted suspension will be inoculated into the drug-containing tube. Incubate at 37°C until 7 days. (Note: Inoculation onto PNB tube is not required in case of Indirect NRA.)

### Reading of tubes {#sec3-18}

Reagents mixture: One part of 50% (v/v) concentrated HCl, two parts of 0.2% (w/v) sulfanilamide, and two parts of 0.1% (w/v) *n*-1-naphthylethylenediamine dihydrochloride. They will be mixed shortly before use.

After 7 days of incubation, 0.5 ml of a reagent mixture will be added to one drug free tube. If any color occurs, the corresponding antibiotic containing tube will be developed by the reagent mixture. If no color change occurs, the tube will be discarded and the other tubes will be re-incubated. The procedure will be repeated at day 10 using the second growth control tube, and if necessary, also at day 14 using the third growth control tube.

Quality control {#sec2-15}
---------------

It is important to perform a quality control (QC) of drug susceptibility testing for drugs testing. Add the standard isolate of*M. tuberculosis* (H ~37~ Rv). Preferably a drug resistant strain should also be included into the QC. If the susceptible H ~37~ Rv shows some resistance, then all the results obtained during the experiment become invalid and the test should be repeated.

Result interpretation {#sec2-16}
---------------------

For direct NRA, if growth appears on PNB containing medium growth is positive for mycobacterial strain other than tubercle bacilli. If there is no growth on PNB medium growth is of*M. tuberculosis* complex.

A strain will be considered resistant if a color change in the drug-containing tube is greater or the same as in 1:10-diluted growth control tube [Figure 1](#F1){ref-type="fig"} and [Figure 2](#F2){ref-type="fig"}.

![Demonstration of nitrate reductase assay results: Sensitive to all tested drugs. GC: Growth control tube without any drug, SM: Growth sensitive to streptomycin, INH: Growth sensitive to isoniazid, RIF: Growth sensitive to rifampicin, EMB: Growth sensitive to ethambutol](JLP-4-112-g004){#F1}

![Demonstration of nitrate reductase assay results: resistant to two drugs. GC: growth control tube without any drug, SM: growth resistant to streptomycin, INH: growth sensitive to isoniazid, RIF: growth resistant to rifampicin, EMB: growth sensitive to ethambutol](JLP-4-112-g005){#F2}
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